1. Home
  2. INDP vs MRM Comparison

INDP vs MRM Comparison

Compare INDP & MRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • INDP
  • MRM
  • Stock Information
  • Founded
  • INDP 2000
  • MRM 2000
  • Country
  • INDP United States
  • MRM Japan
  • Employees
  • INDP N/A
  • MRM N/A
  • Industry
  • INDP Biotechnology: Pharmaceutical Preparations
  • MRM Other Consumer Services
  • Sector
  • INDP Health Care
  • MRM Consumer Discretionary
  • Exchange
  • INDP Nasdaq
  • MRM Nasdaq
  • Market Cap
  • INDP 10.2M
  • MRM 12.2M
  • IPO Year
  • INDP N/A
  • MRM 2020
  • Fundamental
  • Price
  • INDP $0.84
  • MRM $0.99
  • Analyst Decision
  • INDP Strong Buy
  • MRM
  • Analyst Count
  • INDP 2
  • MRM 0
  • Target Price
  • INDP $8.50
  • MRM N/A
  • AVG Volume (30 Days)
  • INDP 25.3K
  • MRM 95.4K
  • Earning Date
  • INDP 03-12-2025
  • MRM 01-01-0001
  • Dividend Yield
  • INDP N/A
  • MRM N/A
  • EPS Growth
  • INDP N/A
  • MRM N/A
  • EPS
  • INDP N/A
  • MRM N/A
  • Revenue
  • INDP N/A
  • MRM $44,462,062.00
  • Revenue This Year
  • INDP N/A
  • MRM N/A
  • Revenue Next Year
  • INDP N/A
  • MRM N/A
  • P/E Ratio
  • INDP N/A
  • MRM N/A
  • Revenue Growth
  • INDP N/A
  • MRM 2.80
  • 52 Week Low
  • INDP $0.81
  • MRM $0.90
  • 52 Week High
  • INDP $3.10
  • MRM $8.39
  • Technical
  • Relative Strength Index (RSI)
  • INDP 39.07
  • MRM 33.16
  • Support Level
  • INDP $0.86
  • MRM $0.93
  • Resistance Level
  • INDP $1.06
  • MRM $1.05
  • Average True Range (ATR)
  • INDP 0.08
  • MRM 0.08
  • MACD
  • INDP 0.00
  • MRM 0.06
  • Stochastic Oscillator
  • INDP 12.80
  • MRM 25.53

About INDP Indaptus Therapeutics Inc.

Indaptus Therapeutics Inc is a pre-clinical biotechnology company engaged in developing a novel and patented systemically-administered anti-cancer and anti-viral immunotherapy. It has developed a proprietary platform that exploits bacteria's natural ability to activate both innate and adaptive cellular immune pathways. The company's pre-clinical candidate Decoy20, has the ability to elicit single-agent activity and durable anti-tumor responses in the combination setting against colorectal, hepatocellular, pancreatic carcinoma, and non-Hodgkin's lymphoma models.

About MRM MEDIROM Healthcare Technologies Inc.

MEDIROM Healthcare Technologies Inc provides health services. The company is a franchiser and operator of healthcare salons and operates in segments namely Relaxation Salon, Digital Preventative Healthcare, and Luxury Beauty Segment. The company generates a majority of its revenue from the Relaxation Salon business segment. Geographically, the company generates a maximum share of its revenue from Japan.

Share on Social Networks: